“Characteristics of CliniMACS® System CD34-Enriched T Cell-Depleted Grafts in a Multicenter Trial for Acute Myeloid Leukemia-Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Protocol 0303”, Biol Blood Marrow Transplant, vol. 18, pp. 690-697, 2012.
, “Characteristics of CD34-Enriched Products Processed at Multiple Centers Using the CliniMACS System - BMT CTN 0303 (Abstract).”, in 16th Annual ISCT (International Society for Cellular Therapy) Meeting, Philadelphia, 2010.
, “Comparison of the safety, vaccine virus shedding and immunogenicity of influenza virus vaccine, trivalent, types A and B, live-cold-adapted (LAIV) administered to HIV-infected and non-HIV-infected adults”, J Infec Dis, vol. 181, pp. 725-8, 2000.
, , “Complement Factor H Polymorphism in Age-Related Macular Degeneration”, Science, vol. 308, pp. 385-389, 2005.
, “Clinical and Immune Responses to Inactivated Influenza A(H1N1)pdm09 Vaccine in Children”, Pediatr Infect Dis J, vol. 33, pp. 865-871, 2014.
, , , “The Cord Blood Transplantation (COBLT) Study: The First Two Years of Recruitment and Collection by the COBLT Cord Blood Banks”, in American Society for Blood and Marrow Transplantation Annual Meeting, Anaheim, CA, 2000.
, “Characteristics Associated With Severe Perineal and Cervical Lacerations During Vaginal Delivery”, Obstet Gynecol, vol. 117, no. 3, pp. 627-635, 2011.
, “Chimpanzee Adenovirus Vector Ebola Vaccine - Preliminary Report”, N Engl J Med, 2014.
, , “Cost-Effectiveness of Age-Related Macular Degeneration Study Supplements in the UK: Combined Trial and Real-World Outcomes Data”, Br J Ophthalmol, 2017.
, , “Comparison of Patient-Reported Outcomes in 5-Year Survivors Who Received Bone Marrow vs Peripheral Blood Unrelated Donor Transplantation: Long-term Follow-up of a Randomized Clinical Trial”, JAMA Oncol, vol. 2, no. 12, pp. 1583-1589, 2016.
, , “Chronic dialysis in children and adolescents. The 1996 Annual Report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)”, Pediatr Nephrol, vol. 13, pp. 404-17, 1999.
“Characteristics of Pigmented Lesions in Type 2 Idiopathic Macular Telangiectasia”, Retina, vol. 38 Suppl 1, pp. S43-S50, 2018.
, “Cross-Reactive Antibody Responses to Novel H5Nx Influenza Viruses Following Homologous and Heterologous Prime-Boost Vaccination with a Prepandemic Stockpiled A(H5N1) Vaccine in Humans”, J Infect Dis, vol. 216, no. suppl_4, pp. S555-S559, 2017.
, “Change in Area of Geographic Atrophy in the Age-Related Eye Disease Study: AREDS Report Number 26”, Arch Ophthalmol, vol. 127, pp. 1168-1174, 2009.
, “Change in Area of Geographic Atrophy in the Age-Related Eye Disease Study: AREDS Report Number 26”, Arch Ophthalmol, vol. 127, pp. 1168-1174, 2009.
, “Central Site Monitoring: Results From a Test of Accuracy in Identifying Trials and Sites Failing Food and Drug Administration Inspection”, Clin Trials, vol. 11, no. 2, pp. 205-217, 2014.
, “Clinical Trial Management: Monitoring Progress, Sites and Safety; New Paradigms for Efficiency”, in 5th Annual Clinical Research Management Workshop at the Yale Center for Clinical Investigation, New Haven, CT, 2012.
, “Cataract Phenotyping Using Serial Examinations in the Age-Related Eye Disease Study (AREDS)”, 2006.
, “Cocaine Use Reduction with Buprenorphine (CURB): Study Methods and Participant Characteristics”, in College on Problems of Drug Dependence (CPDD), Phoenix, AZ, 2015.
,